Deep Venous Thrombosis In Women Research Articles

PB0964 Deep Venous Thrombosis in Women with Locally-Advanced Cervical Cancer: Dynamic Risk Modelling Score

PB0964 Deep Venous Thrombosis in Women with Locally-Advanced Cervical Cancer: Dynamic Risk Modelling Score

Relação entre trombose venosa profunda e seus fatores de risco na população feminina

The aim was to identify the risk factors related to the development of deep venous thrombosis in the female population of Maringa. This is a quantitative research, carried out with the female population attending two vascular surgery outpatient clinics in a municipality in the northwest of Parana, from November 2019 to March 2020, with a structured collection instrument. Data analysis was performed with the aid of the software and description of absolute and relative frequency. The results found showed a high prevalence of deep venous thrombosis in women over 66 years of age, and a significantly higher number of cases in white people. Systemic arterial hypertension was shown to be the main comorbidity in the population studied, followed by venous insufficiency and heart disease. Were concluded that there is a significant relationship between several risk factors and deep vein thrombosis in the female population, as well as an important understanding of each of these factors, a fact that is necessary for an adequate transfer of information to this target population.

Risk factors for deep venous thrombosis in women with ovarian cancer.

We aim to clarify the incidence of deep venous thrombosis (DVT) before treatment in women with ovarian cancer and identify risk factors for DVT.In this prospective study, 110 women underwent venous ultrasonography before cancer treatment and D-dimer levels were measured. We investigated factors predicting DVT by logistic regression.DVT was detected in 25 of 110 women (22.7%) and pulmonary thromboembolism was coexisted in 2 women (1.8%). A total of 21 women (84.4%) with DVT were asymptomatic. D-dimer levels in women with DVT (median, 10.9; range, <0.5–98.2 μg/mL) were significantly higher than those in women without DVT (2.0; <0.5–60.8 μg/mL; P < .01). When 10.9 μg/mL was used as a cutoff value for D-dimer levels to predict DVT, specificity, sensitivity, and positive and negative predictive values were 92.9%, 52.0%, 68.4%, and 86.8%, respectively. The multivariate analysis demonstrated that D-dimer level (odds ratio [OR], 19.7; 95% confidence interval [CI], 5.89–76.76) and clear cell histology (OR, 7.1; 95% CI, 2.12–25.67) were independent factors predicting DVT.Asymptomatic DVT occurred with great frequency before treatment in patients with ovarian cancer. High D-dimer level and clear cell pathology is associated with a higher DVT risk.

Incremental value of hormonal therapy for deep vein thrombosis prediction

Deep venous thrombosis (DVT) management includes prediction rule evaluation to define standard pretest DVT probabilities in symptomatic patients. The aim of this study was to evaluate the incremental usefulness of hormonal therapy to the Wells prediction rules for DVT in women. We studied women undertaking compressive ultrasound scanning for suspected DVT. We adjusted the Wells score for DVT, taking into account the β-coefficients of the logistic regression model. Data discrimination was evaluated by the receiver operating characteristic (ROC) curve. The adjusted score calibration was assessed graphically and by the Hosmer-Lemeshow test. Reclassification tables and the net reclassification index were used for the adjusted score comparison with the Wells score for DVT. We observed 461 women including 103 DVT events. The mean age was 56 years (±21 years). The adjusted logistic regression model included hormonal therapy and six Wells prediction rules for DVT. The adjusted score weights ranged from -4 to 4. Hosmer-Lemeshow test showed a nonsignificant P value (0.69) and the calibration graph showed no differences between the expected and the observed values. The area under the ROC curve was 0.92 [95% confidence interval (CI) 0.90-0.95] for the adjusted model and 0.87 (95% CI 0.84-0.91) for the Wells score for DVT (Delong test, P value < 0.01). Net reclassification index for the adjusted score was 0.22 (95% CI 0.11-0.33, P value < 0.01). Our results suggest an incremental usefulness of hormonal therapy as an independent DVT prediction rule in women compared with the Wells score for DVT. The adjusted score must be evaluated in different populations before clinical use.

SND Rs1799889(-) In The Promotor Of The Plasminogen Activator Inhibitor-1 Gene Contributes To The Risk Of DVT In Women

Summary The incidence of deep venous thrombosis (DVT) depends on the specific genotype, inheritance of prothrombotic polymorphisms and the influence of environmental risk factors. Rs1799889(-) polymorphism in the promotor of PAI-1 gene has been described as a risk factor for hypercoagulable state. Objective: To evaluate the contribution of thrombophilic rs1799889 (-) in the promotor of PAI-1 gene on the incidence of DVT in women and men in groups below and above 45 years of age. Тhere was significantly higher rs1799889 (-) polymorphism carriage among female patients with DVT vs controls (Chi squared =5.506, OR=2.170, p=0.021) but not in male patients (Chi squared =0.090 OR=1.147, p=0.825). A significant contribution of rs1799889 (-) polymorphism to early onset of the disease was found in female patients aged 45+ and carriers of the polymorphism (Chi squared =7.476, p=0.006), but not in young women.

Clinical significance of nursing interventions on preventing lower extremity deep venous thrombosis in women after cesarean

Objective To investigate the contribution of nursing interventions on preventing lower extremity deep venous thrombosis in women after cesarean.Methods 184 women after cesarean were chosen and randomly divided into two groups.After being evaluated by thrombosis risk factor table,pneumatic circulation treatment was performed on patients in observation group for at least 30 minutes,twice a day,who were also required to do more exercises since the day after surgery.The patients in control group just underwent conventional nursing.Blood flow of the lower extremity deep veins was evaluated by Doppler ultrasound for all of the patients on the first day and the seventh day after cesarean to compare the incidence of lower extremity deep vein thrombosis between two groups.Besides,the thigh and crus perimeters were measured everyday to compare the incidence of lower limb swelling between two groups.Results 6 patients in control group were diagnosed as lower extremity deep vein thrombus meanwhile the number in observation group was 0.There was statistical significant difference between two groups (x 2=5.031,P ＜ 0.05).Besides,the number of patients undergoing lower limb swelling in observation group was significantly lower than that in control group (x2=8.528,P ＜ 0.01).Conclusion Nursing intervention can effectively prevent thrombosis lower extremity deep venous thrombosis on women after cesarean. Key words: Nursing interventions; Critical illness maternal; Deep venous thrombosis

Predicting Deep Venous Thrombosis in Pregnancy: Out in “LEFt” Field?

In the nonpregnant general population, deep venous thrombosis (DVT) can be excluded at the initial presentation not only by clinical assessment and review of risk factors, but also by the clinician's assessment of probability using subjective criteria or prediction rules. Because of the absence of a validated prediction rule for diagnosing DVT during pregnancy, diagnosis in pregnant patients depends largely on the use of compression ultrasonography, the diagnostic reference standard that establishes the presence or absence of DVT. The aim of this cross-sectional study was to investigate the predictive accuracy of clinicians' subjective assessment of the probability of DVT in women with suspected DVT and to identify useful objective prediction variables. The participants were 194 unselected pregnant women with suspected first DVT. Potential study patients were identified by clinicians during the initial examination when the clinical assessment was consistent with DVT, and led to consultation with thrombosis experts who obtained informed consent for participation in the study. Before compression ultrasonography testing, the experts examined each study patient and categorized their pretest probability of DVT based on subjective criteria as low, moderate, or high. The sensitivity, specificity, negative predictive value, and likelihood ratios of the clinicians' subjective pretest probability were calculated. Patients defined as DVT positive had abnormal diagnostic compression ultrasonography results at the initial presentation or during serial testing, or had symptomatic DVT or pulmonary embolism on follow-up. Patients with negative compression ultrasonography at presentation and no venous thromboembolism on follow-up were defined as DVT negative. DVT was diagnosed in 17 women (8.8%). The prevalence of DVT in patients with low pretest probability (two-third of patients) was 1.5% (2/131), with a 95% confidence interval of 0.4% to 5.4% (P < 0.001). The prevalence among those with moderate or high pretest probability was considerably higher, 24.6% (15/61), with a 95% confidence interval of 15.5% to 36.7% (P < 0.001). Multivariate analysis identified 3 independent variables that were highly predictive of DVT in pregnant women: left leg symptoms, difference in calf circumference of 2 cm or more, and presentation during the first trimester of pregnancy. DVT was unlikely in the absence of all 3 variables, and its probability increased substantially if 1 or more was present. These findings demonstrate that probability of DVT in pregnant women with suspected DVT may be assessed with use of 3 easily determined objective variables. The data show that DVT is very unlikely with a very low pretest probability.

Role of Gender in the Clinical Presentation of a First Deep Venous Thrombosis (DVT) in Outpatients.

BACKGROUND: As clinical assessment of pretest probability (PTP) is now considered the first step in the diagnostic evaluation of DVT it is important to know if the clinical features of DVT are the same in men and women.OBJECTIVES: We sought to answer the following questions: 1) Is the prevalence of DVT the same in men and women who are referred for diagnostic testing? 2) Are the clinical features of DVT the same in men and women? 3) Does the Wells' clinical prediction model for first DVT perform similarly in men and women?METHODS: We performed a retrospective analysis of individual patient data from three studies that evaluated diagnostic testing in outpatients with a suspected first episode of DVT. Associations were assessed using univariable and multivariable analyses.RESULTS: A total of 1838 patients were eligible for final analyses, of whom 1132 (62%) were women and 706 (38%) were men. DVT was objectively diagnosed in 208 patients (11%). QUESTION 1: The prevalence of DVT was higher in men (14%) than in women (9%) (p=0.001). In a multivariable analysis that included eleven other clinical variables male gender was independently associated with a higher prevalence of DVT (OR 1.5, 95% CI 1.1–2.1). QUESTION 2: Of the confirmed episodes of DVT, “swelling of the entire leg” was observed more often in women (41%) than in men (16%) (p<0.001). This difference was partly explained by more extensive thrombosis in women than in men; the common femoral vein was involved on ultrasound in 48% of women and 22% of men (p< 0.001). The frequency of other clinical features was similar in men and women. QUESTION 3: The prevalence of DVT was higher in men than in women who were categorized by the Wells model as having a low PTP (6.9% vs 3.6%; p=0.025) or a moderate PTP (16.9% vs. 8.7%; p<0.001), but similar in the high PTP category (40% vs 44%; p=0.6). Five clinical features were more strongly associated with presence of DVT in women than in men: “swelling of the entire leg” (OR 7.7 vs. 1.6; p<0.001), “difference in calf circumference >3cm” (OR 8.2 vs. 2.9; p<0.001), “pitting edema” (OR 4.4 vs. 1.8; p=0.004), “age > 60 yrs” (OR 1.8 vs. 0.9; p=0.02) and “bedridden for greater than 3 days” (OR 3.7 vs. 1.4; p=0.05).CONCLUSIONS: Among outpatients referred with a suspected first episode of DVT, the prevalence of DVT is higher in men than in women but DVT is more extensive in women. Entire leg swelling is a more common and important sign of DVT in women than in men and the Wells prediction rule behaves differently in men than in women.

The Effects of Gender on Clinical and Neurological Outcomes after Acute Cervical Spinal Cord Injury

The potential clinical relevance of gender on clinical and neurological outcome after spinal cord injury (SCI) has received little attention. In order to address this issue, we examined all consecutive cases of acute traumatic cervical SCI admitted to our institution from 1998 to 2000. There were 38 males (ages 17-89 years, mean of 51.6) and 17 females (ages 18-84 years, mean of 63.2). Both groups were comparable regarding level (C1 to C7) and severity of SCI (ASIA A to D) at admission. Age differences between the groups approached significance (p = 0.057), and thus this factor was treated as a covariate in the analysis. Co-morbidities were as frequent in men (86.8%) as in women (76.5%). The therapeutic approaches, length-of-stay in the acute care unit, mortality, and discharge disposition were similar in men and women. During hospitalization, 44.7% of men and 52.9% of women developed post-SCI secondary complications without any significant gender-related differences. Both groups showed a similar incidence of infections, cardiovascular complications, thromboembolism, and pressure sores. Univariate analysis revealed a trend for higher incidence of psychiatric complications (p = 0.054) and deep venous thrombosis (p = 0.092) in women, which was confirmed by multivariate analysis. Neurological outcome was not correlated with gender. A similar number of males and females (42.1%, 47.1%) showed evidence of neurological recovery as revealed by an improvement in ASIA scores. Moreover, 18.4% of males and 29.4% of females recovered to ASIA E status. Our data suggest a shift in the demographics of acute SCI with an increasing incidence in elderly women. Although neurological outcomes were not significantly related to gender, we observed a trend for higher rates of reactive depression and deep venous thrombosis in women. These issues may be of key clinical importance in developing improved management protocols for SCI so as to maximize functional recovery and quality-of-life.

A comparison of thromboembolic prophylaxis in gynecologic oncology patients

The objective of this study was to compare two methods of thromboembolic prophylaxis: sequential compression devices alone (SCDs) vs. SCDs with subcutaneous low-dose unfractionated heparin (UH). A retrospective cohort study was conducted of 168 patients who had undergone surgery for suspected gynecological malignancies. These patients were examined for associated risk factors, method of prophylaxis, and incidence of clinically significant thromboembolic events. Of these patients, 94 (56%) received perioperative and postoperative sequential compression devices alone, while 74 (44%) received both SCDs and subcutaneous low-dose UH. The postoperative course of these patients, while in the hospital and after discharge, was followed for clinically evident thromboembolic complications. Univariate and multivariate analyses were performed. The two groups were comparable in terms of most risk factors, including age, stage, height, weight, body surface area, estimated blood loss, total anesthesia time, and nodal disease. Six of 94 patients (6.4%) in the SCDs group suffered from venous thromboembolism, while four of 74 patients (5.4%) who received both SCDs and low-dose UH had a thromboembolic event (chi2 P = 0.79). There was no difference in postoperative changes in platelet counts between the two groups. Heparin added additional cost, 105 extra minutes of nursing time per patient per admission, and additional pain for the patient. In conclusion, the addition of subcutaneous low-dose unfractionated heparin to SCDs for prophylaxis against deep venous thrombosis in women undergoing surgery for gynecologic malignancies does not improve the outcome. Adding heparin was more expensive, time consuming, and painful. Heparin should not be used with SCDs unless an additional benefit can be demonstrated in a randomized controlled trial.

Localization of acute deep venous thrombosis in women taking oral contraceptives.

In an investigation of 62 patients from fifteen to forty-five years of age with acute deep venous thrombosis of the lower limb, it was found that the disease had originated most often in the calf veins in men and in women not using oral contraceptives. In women using oral contraceptives, the thrombosis started least often in the calf veins and most often in the iliofemoral veins. A tentative explanation of this difference in localization of thrombosis of the leg with the use of oral contraceptives is given.